Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Clinical trial NCT01441440 · COMPLETED
Trial details
- NCT number
- NCT01441440
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2014-03-01
- Enrollment
- 538
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.